Page results
-
UCLH needs to reduce the amount we consume per patient, re-use and re-manufacture what we can and ensure that what we do use has minimal environmental impact. We also need to ensure our suppliers match our environmental ambitions. This page explores our progress so far.
-
About the RLHIM Pharmacy The RLHIM pharmacy is run by pharmacists who specialise in natural medicines, and it is both a hospital and a retail pharmacy. The RLHIM hospital pharmacy The…
-
What is Cognitive Behavioural Therapy (CBT)? CBT is evidence-based therapy. It involves working with a practitioner collaboratively, to understand the problems that are keeping you stuck, and to…
-
This page has been written for parents of children with congenital CMV infection.
-
As with any form of pain management, different resources or techniques will suit different people. Please remember that you may need to try out more than one book, CD or website before you find…
-
There is a lot of information on the internet; some of the stuff you find might not always be reliable so try to use websites you can trust. Here are some websites that have been recommended by…
-
The department of medical physics and biomedical engineering provides expert physical science support to activities both within UCLH and to a wide range of external partners.
-
Specialist multi-disciplinary team (MDT) At UCLH you will be looked after by a specialist multidisciplinary team (MDT). The MDT consist of doctors, nurses and coordinators who all have specialist…
-
Exam guidance for children and young people with type 1 diabetes
File results
-
FOI/2024/0393 - Translation service/ communication spend
-
FOI/2024/0385 - Immunoglobulin vials (by brands) distributed to patients
-
FOI/2024/0381 - Proton Beam Therapy Centre material use, architectural technology and performance
-
FOI/2024/0380 - Appraisal review/ Responsible Officer/ Revalidation Officer
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0357 - Multiple myeloma treatments
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust